AXQ Capital LP Acquires Shares of 66,262 LifeStance Health Group, Inc. $LFST

AXQ Capital LP bought a new position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 66,262 shares of the company’s stock, valued at approximately $343,000.

Other hedge funds have also recently modified their holdings of the company. Jacobs Levy Equity Management Inc. purchased a new stake in LifeStance Health Group during the 1st quarter worth approximately $7,932,000. Adage Capital Partners GP L.L.C. lifted its position in shares of LifeStance Health Group by 43.8% in the first quarter. Adage Capital Partners GP L.L.C. now owns 230,000 shares of the company’s stock valued at $1,532,000 after acquiring an additional 70,000 shares in the last quarter. Victory Capital Management Inc. boosted its stake in shares of LifeStance Health Group by 2,599.0% in the first quarter. Victory Capital Management Inc. now owns 370,598 shares of the company’s stock worth $2,468,000 after acquiring an additional 356,867 shares during the last quarter. TD Asset Management Inc purchased a new stake in shares of LifeStance Health Group during the second quarter worth approximately $780,000. Finally, Nuveen LLC purchased a new stake in shares of LifeStance Health Group during the first quarter worth approximately $6,928,000. Institutional investors and hedge funds own 85.50% of the company’s stock.

LifeStance Health Group Stock Up 0.8%

Shares of NASDAQ LFST opened at $6.49 on Tuesday. The company has a market capitalization of $2.52 billion, a P/E ratio of -216.33 and a beta of 1.16. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.58 and a quick ratio of 1.58. The company has a 50 day simple moving average of $5.51 and a 200-day simple moving average of $5.25. LifeStance Health Group, Inc. has a 1 year low of $3.74 and a 1 year high of $8.30.

LifeStance Health Group (NASDAQ:LFST) last issued its quarterly earnings data on Thursday, November 6th. The company reported $0.02 earnings per share for the quarter, topping the consensus estimate of ($0.01) by $0.03. LifeStance Health Group had a negative return on equity of 0.62% and a negative net margin of 0.67%.The company had revenue of $363.81 million during the quarter, compared to analyst estimates of $355.06 million. During the same period in the prior year, the business posted ($0.02) earnings per share. The firm’s revenue for the quarter was up 16.3% compared to the same quarter last year. LifeStance Health Group has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. On average, equities research analysts predict that LifeStance Health Group, Inc. will post -0.18 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts have issued reports on LFST shares. BMO Capital Markets started coverage on shares of LifeStance Health Group in a research note on Thursday, November 13th. They set an “outperform” rating and a $8.00 target price on the stock. UBS Group raised their price target on shares of LifeStance Health Group from $9.00 to $10.00 and gave the stock a “buy” rating in a research note on Friday, November 7th. Weiss Ratings restated a “sell (d-)” rating on shares of LifeStance Health Group in a research report on Wednesday, November 19th. BTIG Research increased their price objective on shares of LifeStance Health Group from $8.00 to $9.00 and gave the company a “buy” rating in a report on Thursday, November 6th. Finally, Zacks Research lowered shares of LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 5th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, LifeStance Health Group has an average rating of “Moderate Buy” and a consensus target price of $9.00.

LifeStance Health Group Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.